Pharmafile Logo
Pharmafocus logo
Advanced Search

AviadoBio Signs Exclusive License Agreement with Neurgain Technologies for Novel Gene Therapy Spinal Delivery Technology

February 24, 2023
Business Services

LONDON–(BUSINESS WIRE)–AviadoBio, a pioneering gene therapy company developing and delivering transformative medicines for neurodegenerative disorders and Neurgain Technologies, Inc., an …

News
Press release

Sanofi and Glooko partner on ‘connected insulin’ tech

February 24, 2023
Medical Communications

Big pharma company Sanofi aims to develop insulin-based therapies that can be connected with glucose monitoring devices, making it easier …

News

Mologic Inc’s COVID-19 rapid antigen self-test receives FDA Emergency Use Authorization for home use

February 24, 2023
Medical Communications

US subsidiary of Global Access Diagnostics (GADx) ‒ a developer of lateral flow and rapid diagnostic technologies, products and services …

News

NICE approved BMS’s Opdivo for lung cancer

February 24, 2023
Medical Communications

Bristol-Myers Squibb’s (BMS) immunotherapy drug Opdivo (nivolumab) has become the first to be cleared for NHS use alongside chemotherapy as …

News

Moda Living and LloydsPharmacy partner to offer residents prescription service

February 24, 2023
Medical Communications

Moda Living has announced a partnership with LloydsPharmacy to bring residents a ‘Health Concierge Service’ through VideoGP.   VideoGP will …

News

UiPath Helps Mitsubishi Tanabe Pharma Accelerate Business Operational Efficiency

February 23, 2023
Business Services

February 23, 2023 – UiPath (NYSE: PATH), a leading enterprise automation software company, today announced that Mitsubishi Tanabe Pharma Corporation, …

News
Press release

NICE recommends first immunotherapychemotherapy combination for neoadjuvant treatment of resectable non-small-cell lung cancer

February 23, 2023
Business Services

(Uxbridge, Middlesex, 22 February 2023) – Bristol Myers Squibb (BMS) has announced that the National Institute for Health and Care …

News
Press release

LEADING BUILD TO RENT OPERATOR LAUNCHES SECTOR-FIRST PRESCRIPTION SERVICE WITH NATIONAL PHARMACY CHAIN

February 23, 2023
Business Services

Moda Living, the UK’s leading developer and operator of rental communities, has today announced a partnership with VideoGP by LloydsPharmacy, …

News
Press release

Pandemic Antiviral Discovery (PAD) makes first investments to support the development of new antiviral medicines for future pandemics

February 23, 2023
Business Services

Today, the partners in Pandemic Antiviral Discovery (PAD) initiative announced grants totalling more than USD 26 million for 14 research …

News
Press release

8 out of 10 pharmaceutical companies say developing Covid tests and vaccines has impacted their development pipeline

February 23, 2023
Business Services

LONDON 23rd February 2023 

News
Press release

BiomX shares positive data from first bacteriophage trial

February 23, 2023
Research and Development

BiomX has shared data from a new study in cystic fibrosis (CF) patients, assessing whether bacteriophages could be a new …

News

Redx Pharma agrees to $425m all-share merger with Jounce Therapeutics

February 23, 2023
Research and Development

UK-based clinical-stage biotech company Redx Pharma has agreed to a $425m all-share merger with US drug research business Jounce Therapeutics. …

News

AstraZeneca signs $63m agreement for gastric cancer treatment

February 23, 2023
Medical Communications

AstraZeneca has announced that it has signed an exclusive license agreement (ELA) with KYM Biosciences Inc for CMG901, which is …

News

£1.6bn of research and development funding “surrendered” back to UK Treasury

February 23, 2023
Medical Communications

A pot of £1.6bn which was originally allocated as the UK’s contribution to the €96bn Horizon Europe research funding programme …

News

OSE Immunotherapeutics Updates on Anti-IL-7 Receptor Antagonist OSE-127/S95011, a Breakthrough Approach in Chronic Inflammatory Autoimmune Diseases and Hematology

February 22, 2023
Business Services

Nantes, France – February 22, 2023, 6:00 p.m.

News
Press release

Karyopharm and Menarini gain full MHRA approval for multiple myeloma drug

February 22, 2023
Research and Development

Pharmaceutical companies Karyopharm Therapeutics and Menarini Group have announced that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) have …

News

FDA grants approval to Beckley Psytech’s short-acting psychedelic trial

February 22, 2023
Research and Development

Beckley Psytech, a private, clinical-stage biotech company, announced that the FDA has granted Investigational New Drug (IND) approval for their …

News

ViiV Healthcare receives EU Marketing Authorisation for Triumeq PD, the first dispersible single tablet regimen containing dolutegravir, a once-daily treatment for children living with HIV in Europe

February 22, 2023
Business Services

  

News
Press release

PHARMANOVIA ENTERS IN-LICENSING AGREEMENT WITH AXSOME THERAPEUTICS TO MARKET AND FURTHER DEVELOP SUNOSI® (SOLRIAMFETOL), A FIRST-IN-CLASS TREATMENT FOR EXCESSIVE DAYTIME SLEEPINESS (EDS) IN PEOPLE WITH NARCOLEPSY AND OBSTRUCTIVE SLEEP APNOEA

February 22, 2023
Business Services

BASILDON, UK, 22 February 2023   Pharmanovia, a global pharmaceutical company that revitalises, extends and expands the lifecycle of already …

News
Press release

Relation Therapeutics announces launch of flagship integrated wet–dry laboratory at the heart of London’s Knowledge Quarter

February 22, 2023
Business Services

London, February 22, 2023 – Relation Therapeutics, a leader in the use of high-resolution biology, machine learning and clinical insights …

News
Press release
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025